A citation-based method for searching scientific literature


List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Presence of alternative lengthening of telomeres mechanism in patients with glioblastoma identifies a less aggressive tumor type with longer survival.
Kerrie L McDonald, Julie McDonnell, Alessandra Muntoni, Jeremy D Henson, Monika E Hegi, Andreas von Deimling, Helen R Wheeler, Ray J Cook, Michael T Biggs, Nicholas S Little,[...]. J Neuropathol Exp Neurol 2010
63
100


Telomere sequence content can be used to determine ALT activity in tumours.
Michael Lee, Erdahl T Teber, Oliver Holmes, Katia Nones, Ann-Marie Patch, Rebecca A Dagg, Loretta M S Lau, Joyce H Lee, Christine E Napier, Jonathan W Arthur,[...]. Nucleic Acids Res 2018
20
100

Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors.
Joshua Mangerel, Aryeh Price, Pedro Castelo-Branco, Jack Brzezinski, Pawel Buczkowicz, Patricia Rakopoulos, Diana Merino, Berivan Baskin, Jonathan Wasserman, Matthew Mistry,[...]. Acta Neuropathol 2014
27
100

Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Gary A Ulaner, Andrew R Hoffman, Jesse Otero, Hsuan-Ying Huang, Zhiquan Zhao, Madhu Mazumdar, Richard Gorlick, Paul Meyers, John H Healey, Marc Ladanyi. Genes Chromosomes Cancer 2004
69
100

Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies.
Jennie N Jeyapalan, Aaron Mendez-Bermudez, Nadia Zaffaroni, Yuri E Dubrova, Nicola J Royle. Int J Cancer 2008
41
100


Telomere length abnormalities and telomerase RNA component expression in gastroenteropancreatic neuroendocrine tumors.
Hee Sung Kim, Hye Seung Lee, Kyung Han Nam, Jiwoon Choi, Woo Ho Kim. Anticancer Res 2015
12
100

TERT-mediated and ATRX-mediated Telomere Maintenance and Neuroblastoma.
Xiao-Feng Duan, Qiang Zhao. J Pediatr Hematol Oncol 2018
9
100

Potential clinical role of telomere length in human glioblastoma.
D La Torre, M Aguennouz, A Conti, M Giusa, G Raffa, R V Abbritti, A Germano', F F Angileri. Transl Med UniSa 2011
6
100

In Japanese patients with papillary thyroid carcinoma, TERT promoter mutation is associated with poor prognosis, in contrast to BRAF V600E mutation.
Almira Nasirden, Tsuyoshi Saito, Yuki Fukumura, Kieko Hara, Keisuke Akaike, Aiko Kurisaki-Arakawa, Miki Asahina, Atsushi Yamashita, Ran Tomomasa, Takuo Hayashi,[...]. Virchows Arch 2016
27
100

Spontaneous occurrence of telomeric DNA damage response in the absence of chromosome fusions.
Anthony J Cesare, Zeenia Kaul, Scott B Cohen, Christine E Napier, Hilda A Pickett, Axel A Neumann, Roger R Reddel. Nat Struct Mol Biol 2009
170
100

Telomerase activation by genomic rearrangements in high-risk neuroblastoma.
Martin Peifer, Falk Hertwig, Frederik Roels, Daniel Dreidax, Moritz Gartlgruber, Roopika Menon, Andrea Krämer, Justin L Roncaioli, Frederik Sand, Johannes M Heuckmann,[...]. Nature 2015
296
100

FANCM, BRCA1, and BLM cooperatively resolve the replication stress at the ALT telomeres.
Xiaolei Pan, William C Drosopoulos, Louisa Sethi, Advaitha Madireddy, Carl L Schildkraut, Dong Zhang. Proc Natl Acad Sci U S A 2017
53
100

Transcriptionally active chromatin recruits homologous recombination at DNA double-strand breaks.
François Aymard, Beatrix Bugler, Christine K Schmidt, Emmanuelle Guillou, Pierre Caron, Sébastien Briois, Jason S Iacovoni, Virginie Daburon, Kyle M Miller, Stephen P Jackson,[...]. Nat Struct Mol Biol 2014
347
100

Clinicopathological analysis of ATRX, DAXX and NOTCH receptor expression in angiosarcomas.
Gauri Panse, John Sa Chrisinger, Cheuk H Leung, Davis R Ingram, Samia Khan, Khalida Wani, Heather Lin, Alexander J Lazar, Wei-Lien Wang. Histopathology 2018
14
100


Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas.
Kathleen Dorris, Matthew Sobo, Arzu Onar-Thomas, Eshini Panditharatna, Charles B Stevenson, Sharon L Gardner, Mariko D Dewire, Christopher R Pierson, Randal Olshefski, Sandra A Rempel,[...]. J Neurooncol 2014
27
100


The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas.
Malak Abedalthagafi, Joanna J Phillips, Grace E Kim, Sabine Mueller, Daphne A Haas-Kogen, Roxanne E Marshall, Sidney E Croul, Mariarita R Santi, Jing Cheng, Shengmei Zhou,[...]. Mod Pathol 2013
74
100

Telomerase activity in malignant and benign renal tumors.
M Müller, R Heicappell, H Krause, J Sachsinger, C Porsche, K Miller. Eur Urol 1999
16
100

Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors.
Aatur D Singhi, Ta-Chiang Liu, Justin L Roncaioli, Dengfeng Cao, Herbert J Zeh, Amer H Zureikat, Allan Tsung, J Wallis Marsh, Kenneth K Lee, Melissa E Hogg,[...]. Clin Cancer Res 2017
101
100


Alternative lengthening of telomeres and ATRX/DAXX loss can be reliably detected in FNAs of pancreatic neuroendocrine tumors.
Christopher J VandenBussche, Derek B Allison, Mindy K Graham, Vivek Charu, Anne Marie Lennon, Christopher L Wolfgang, Ralph H Hruban, Christopher M Heaphy. Cancer Cytopathol 2017
26
100

Multiple mechanisms of telomere maintenance exist in liposarcomas.
Jay E Johnson, Robert J Varkonyi, Jaclyn Schwalm, Ryan Cragle, Andres Klein-Szanto, Arthur Patchefsky, Edna Cukierman, Margaret von Mehren, Dominique Broccoli. Clin Cancer Res 2005
50
100

ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis.
Benedikt Wiestler, David Capper, Tim Holland-Letz, Andrey Korshunov, Andreas von Deimling, Stefan Michael Pfister, Michael Platten, Michael Weller, Wolfgang Wick. Acta Neuropathol 2013
206
100

ATRX mRNA expression combined with IDH1/2 mutational status and Ki-67 expression refines the molecular classification of astrocytic tumors: evidence from the whole transcriptome sequencing of 169 samples samples.
Jinquan Cai, Pei Yang, Chuanbao Zhang, Wei Zhang, Yanwei Liu, Zhaoshi Bao, Xing Liu, Wenzhong Du, Hongjun Wang, Tao Jiang,[...]. Oncotarget 2014
53
100

Integrative genomic and transcriptomic analysis of leiomyosarcoma.
Priya Chudasama, Sadaf S Mughal, Mathijs A Sanders, Daniel Hübschmann, Inn Chung, Katharina I Deeg, Siao-Han Wong, Sophie Rabe, Mario Hlevnjak, Marc Zapatka,[...]. Nat Commun 2018
93
100

Alternative lengthening of telomeres: models, mechanisms and implications.
Anthony J Cesare, Roger R Reddel. Nat Rev Genet 2010
583
100

Telomerase as a "stemness" enzyme.
Feng Kong, ChengYun Zheng, DaWei Xu. Sci China Life Sci 2014
33
100

Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas.
Jau-Yu Liau, Jia-Huei Tsai, Ching-Yao Yang, Jen-Chieh Lee, Cher-Wei Liang, Hung-Han Hsu, Yung-Ming Jeng. Hum Pathol 2015
31
100

Telomerase and telomere biology in hematological diseases: A new therapeutic target.
Alessandro Allegra, Vanessa Innao, Giuseppa Penna, Demetrio Gerace, Andrea G Allegra, Caterina Musolino. Leuk Res 2017
12
100

Alternative lengthening of telomeres as a prognostic factor in malignant fibrous histiocytomas of bone.
Toshihiro Matsuo, Shoji Shimose, Tadahiko Kubo, Jun Fujimori, Yuji Yasunaga, Mitsuo Ochi. Anticancer Res 2010
12
100

Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma.
Raffaella Villa, Maria Grazia Daidone, Rosita Motta, Lorenza Venturini, Cinzia De Marco, Alberto Vannelli, Shigeki Kusamura, Dario Baratti, Marcello Deraco, Aurora Costa,[...]. Clin Cancer Res 2008
50
100


Lack of telomerase activity in lung carcinoids is dependent on human telomerase reverse transcriptase transcription and alternative splicing and is associated with long telomeres.
Nadia Zaffaroni, Raffaella Villa, Ugo Pastorino, Rosalia Cirincione, Matteo Incarbone, Marco Alloisio, Maria Curto, Silvana Pilotti, Maria Grazia Daidone. Clin Cancer Res 2005
28
100

Loss of ATRX and DAXX expression identifies poor prognosis for smooth muscle tumours of uncertain malignant potential and early stage uterine leiomyosarcoma.
Tania L Slatter, Howard Hsia, Ari Samaranayaka, Peter Sykes, William Bill Clow, Celia J Devenish, Tim Sutton, Janice A Royds, Philip P Ip, Annie N Cheung,[...]. J Pathol Clin Res 2015
22
100

Frequent alternative lengthening of telomeres and ATRX loss in adult NF1-associated diffuse and high-grade astrocytomas.
Fausto J Rodriguez, M Adelita Vizcaino, Jaishri Blakeley, Christopher M Heaphy. Acta Neuropathol 2016
18
100

Telomerase activity in pleural malignant mesotheliomas.
Amy Y M Au, Torben Hackl, Thomas R Yeager, Scott B Cohen, Harvey I Pass, Curtis C Harris, Roger R Reddel. Lung Cancer 2011
14
100


Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma.
Gary A Ulaner, Hsuan-Ying Huang, Jesse Otero, Zhiquan Zhao, Leah Ben-Porat, Jaya M Satagopan, Richard Gorlick, Paul Meyers, John H Healey, Andrew G Huvos,[...]. Cancer Res 2003
135
100

Telomere alterations in neurofibromatosis type 1-associated solid tumors.
Fausto J Rodriguez, Mindy K Graham, Jacqueline A Brosnan-Cashman, John R Barber, Christine Davis, M Adelita Vizcaino, Doreen N Palsgrove, Caterina Giannini, Melike Pekmezci, Sonika Dahiya,[...]. Acta Neuropathol Commun 2019
5
100

ATRX loss induces telomere dysfunction and necessitates induction of alternative lengthening of telomeres during human cell immortalization.
Fei Li, Zhong Deng, Ling Zhang, Caizhi Wu, Ying Jin, Inah Hwang, Olga Vladimirova, Libo Xu, Lynnie Yang, Bin Lu,[...]. EMBO J 2019
23
100

Long-term in vitro treatment with telomerase inhibitor MST-312 induces resistance by selecting long telomeres cells.
Karollyne da Silva Morais, Daniel da Silva Arcanjo, Giselle Pinto de Faria Lopes, Guilherme Guimarães da Silva, Tales Henrique Andrade da Mota, Thiago Rodrigues Gabriel, Doralina do Amaral Rabello Ramos, Fábio Pittella Silva, Diêgo Madureira de Oliveira. Cell Biochem Funct 2019
3
100

Long-term exposure to MST-312 leads to telomerase reverse transcriptase overexpression in MCF-7 breast cancer cells.
Karollyne S Morais, Ana Flávia R Guimarãesb, Doralina A R Ramos, Fábio P Silva, Diêgo M de Oliveira. Anticancer Drugs 2017
7
100

Human telomerase activity regulation.
Aneta Wojtyla, Marta Gladych, Blazej Rubis. Mol Biol Rep 2011
62
100

Altered telomeres in tumors with ATRX and DAXX mutations.
Christopher M Heaphy, Roeland F de Wilde, Yuchen Jiao, Alison P Klein, Barish H Edil, Chanjuan Shi, Chetan Bettegowda, Fausto J Rodriguez, Charles G Eberhart, Sachidanand Hebbar,[...]. Science 2011
644
100

Telomeres and telomerase in sarcomas.
Toshihiro Matsuo, Shoji Shimose, Tadahiko Kubo, Jun Fujimori, Yuji Yasunaga, Mitsuo Ochi. Anticancer Res 2009
10
100

[Telomere Recombination in Normal Mammalian Cells].
N S Zhdanova, N B Rubtsov. Genetika 2016
4
100



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.